posted
Martin Nutraceuticals Inc. Opens Negotiations to Enter the Australian Market
PrintE-mailDisable live quotesRSSDigg itDel.icio.us
Last Update: 9:45 AM ET Mar 26, 2007
RENO, Nev., Mar 26, 2007 (BUSINESS WIRE) -- Martin Nutraceuticals Inc. (PINKSHEETS:MNCL) is pleased to announce that it entered into negotiations with JPS Trading Co., a company focused on distribution of supplements and natural products in Australia. JPS Trading Co. will represent all of Martin's flagship products, Arthrizyme, Oxygenol and Maximum Slim, and will also represent Dr. Martin's book, Medical Crisis - Secrets Your Doctor Won't Share With You. The marketing strategy by JPS will focus on mass distribution of Martin's flagship ingestible products into major retail and supplement centers. The strategy of marketing of the book will follow the North American model and will be sold through a direct sales DRTV (infomercial) campaign. "This could be a fantastic opportunity for Martin Nutraceuticals," states Harvey Panesar, President of Martin Nutraceuticals Inc., "We are very excited about the possibilities of entering the Australian market, which is an absolute bonus since we have been focusing on getting our infomercial/DRTV campaign to air in North America. We were not actively searching for other markets outside of North America, but when this opportunity arose, we could not turn it down - it just made sense to at least explore where it could lead." The Australian market size for nutraceuticals has been consistently rising over the last few years. The current market size for nutraceuticals in Australia has exceeded over $900 million; largely due in part to 60% of the Australian population currently using a nutraceutical product, which equivocates to 7.5 million Australian consumers. Source: Aztec Information System For more information, please contact Investor Relations at (973) 351-3868 or http://www.martinnutra.com/ About Martin Nutraceuticals Inc. Martin Nutraceuticals Inc. is a company focused on providing a better health and lifestyle through natural products. Martin Nutraceuticals flagship products include Arthrizyme(TM) for general joint pain and Oxygenol(TM) for anti-oxidation and Maximum Slim(TM) for weight control. Arthrizyme(TM) is a unique blend of systemic enzymes proven to rapidly reduce inflammation in joints and muscles. Arthrizyme(TM) is not limited to anti-inflammatory effects; it also assists the body in the healing process by breaking down fibrin in joints and muscles. Arthrizyme(TM) differs from all other natural arthritis remedies and was designed to work for all types of arthritis and in all joints of the body. Arthrizyme(TM) is fast acting, usually improving symptoms within the first few days. Safe Harbor Statement This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The risks and uncertainties that may affect the operations, performance development and results of the Company's business include but are not limited to fluctuations in financial results, availability and customer acceptance of our products and services, the impact of competitive products, services and pricing, general market trends and conditions.
Posts: 196 | From: usa | Registered: Feb 2006
| IP: Logged |
posted
Martin Nutraceuticals Inc. Opens Negotiations to Enter the $900 Million Nutraceutical and Supplement Australian Market
PrintE-mailDisable live quotesRSSDigg itDel.icio.us
Last Update: 6:30 AM ET Mar 27, 2007
RENO, NV, Mar 27, 2007 (BUSINESS WIRE) -- Martin Nutraceuticals Inc. (PINKSHEETS: MNCL.PK) is pleased to announce that it entered into negotiations with JPS Trading Co., a company focused on distribution of supplements and natural products in Australia. JPS Trading Co. will represent all of Martin's flagship products, Arthrizyme, Oxygenol and Maximum Slim, and will also represent Dr. Martin's book, Medical Crisis - Secrets Your Doctor Won't Share With You. The marketing strategy by JPS will focus on mass distribution of Martin's flagship ingestible products into major retail and supplement centers. The strategy of marketing of the book will follow the North American model and will be sold through a direct sales DRTV (infomercial) campaign. "This could be a fantastic opportunity for Martin Nutraceuticals," states Harvey Panesar, President of Martin Nutraceuticals Inc., "We are very excited about the possibilities of entering the Australian market, which is an absolute bonus since we have been focusing on getting our infomercial/DRTV campaign to air in North America. We were not actively searching for other markets outside of North America, but when this opportunity arose, we could not turn it down - it just made sense to at least explore where it could lead." The Australian market size for nutraceuticals has been consistently rising over the last few years. The current market size for nutraceuticals in Australia has exceeded over $900 million; largely due in part to 60% of the Australian population currently using a nutraceutical product, which equivocates to 7.5 million Australian consumers. Source: Aztec Information System
Posts: 196 | From: usa | Registered: Feb 2006
| IP: Logged |
posted
Martin Nutraceuticals Has Translated the Medical Crisis Book in French to Capitalize on the Estimated Half a Billion Dollar Quebec Market
PrintE-mailDisable live quotesRSSDigg itDel.icio.us
Last Update: 6:30 AM ET Mar 29, 2007
RENO, Nev., Mar 29, 2007 (BUSINESS WIRE) -- Martin Nutraceuticals Inc. (MNCL.PK) is pleased to announce that it has completed the translation of Dr. Martin's New book - Medical Crisis, Secrets Your Doctor Won't Share With You, into the French Language. According to Statistics Canada, Canadian book sales exceeded over 2 billion dollars annually in the recent years and the Province of Quebec represented over 22% of those sales. "It seemed like the logical thing to do. We are listed with major retail stores, health stores and pharmacies throughout Quebec so why not try to piggy back our book with current retailers that already carry our flagship products," stated Harvey Panesar, President of Martin Nutraceuticals Inc. "Our business model remains consistent in that we will use the DRTV (infomercial) medium for US market penetration and the retail medium through Dr. Martin's brand recognition in Canada. We had earlier announced that we had a purchase order from Chapter/Indigo, the largest book retailer in Canada and we are now hoping with our book being available in French we can make inroads with new book retailers that would not have been other wise available to us." Martin Nutraceuticals new website for the Medical Crisis book, www.medicalcrisisthebook.com will be unveiled shortly and will include the new French copy. For more information, please contact Investor Relations at (973) 351-3868 or http://www.martinnutra.com/ About Martin Nutraceuticals Inc. Martin Nutraceuticals Inc. is a company focused on providing a better health and lifestyle through natural products. Martin Nutraceuticals flagship products include Arthrizyme(TM) for general joint pain and Oxygenol(TM) for anti-oxidation and Maximum Slim(TM) for weight control. Arthrizyme(TM) is a unique blend of systemic enzymes proven to rapidly reduce inflammation in joints and muscles. Arthrizyme(TM) is not limited to anti-inflammatory effects; it also assists the body in the healing process by breaking down fibrin in joints and muscles. Arthrizyme(TM) differs from all other natural arthritis remedies and was designed to work for all types of arthritis and in all joints of the body. Arthrizyme(TM) is fast acting, usually improving symptoms within the first few days. Safe Harbor Statement This release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The risks and uncertainties that may affect the operations, performance development and results of the Company's business include but are not limited to fluctuations in financial results, availability and customer acceptance of our products and services, the impact of competitive products, services and pricing, general market trends and conditions.
Posts: 196 | From: usa | Registered: Feb 2006
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
